SCHEMBL7908696

SCHEMBL7908696

CCCCC(c1ccc(N)cc1)c1ncc[nH]1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.42
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
F2RL1 P55085 10/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
FPR2 P25090 2/20 0.34
MAPT P10636 1/20 0.33
MMP2 P08253 1/20 0.32
MMP3 P08254 1/20 0.32
CYP17A1 P05093 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9803992 0.87 CYP19A1 (0.43) CYP19A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7905623 0.85 FPR2 (0.40) CYP19A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL19642925 0.83 CYP1A2 (0.44) CYP19A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL11230021 0.83 CHRM2 (0.48) CYP19A1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL10686017 0.82 CYP19A1 (0.45) CYP19A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL28566835 0.78 CYP1A2 (0.36) CYP19A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL14880753 0.78 CYP1A2 (0.42) CYP19A1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL12112001 0.78 CYP19A1 (0.47) CYP19A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL8101640 0.78 CYP19A1 (0.47) CYP19A1CYP1A2CYP3A4CYP2C9CYP2C19
Oxalic Acid SCHEMBL1507978 0.77 ADRA2A (0.42) CYP19A1CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6197975-B1 7-AZABICYCLO(2.2.1)HEPTANE-7-CARBONYL-SUBSTITUTED 2-PHENYLINDOLE DERIVATIVES; SEXUAL DISORDERS; ANTICARCINOGENIC AGENTS MERCK & CO. , INC. 2001-03-06 US disclosed
EP-0882040-A4 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO INC (US) 1999-02-10 EP disclosed
EP-0882040-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE Merck & Co., Inc. (US) 1998-12-09 EP disclosed
WO-1997021707-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO., INC. (US) 1997-06-19 WO disclosed